Study of ITP and stroke patients
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation, Immune system & allergy clinical trials.
This study follows people who have both immune thrombocytopenia (ITP) and a recent stroke. It aims to learn more about how these conditions interact and what treatments work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with immune thrombocytopenia (ITP) and then had an acute ischemic stroke.
- You were treated at Peking University People's Hospital at any time after January 1, 2005.
- You do not have a severe mental disorder that would make follow-up difficult.
- The researchers must agree that you are suitable for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with immune thrombocytopenia (ITP) to learn more about the condition over time. ITP is a disorder where the immune system attacks platelets, which help blood clot. The goal is to better understand the disease and improve care.
This study looks back at medical records of people with newly diagnosed or persistent ITP (lasting up to 12 months) to understand how the condition is treated in real life. Anyone who received standard ITP treatments or none at all may be included.
This trial tests an IV medicine called V-IMMUNE® for people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The study aims to see if V-IMMUNE® can safely raise platelet counts in both children and adults.
This study looks at how people with immune thrombocytopenia (ITP) are doing after having their spleen removed. By tracking your health over time, researchers hope to learn more about the long-term results of this treatment.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study looks at specific immune blood tests to understand why some people with immune thrombocytopenia (ITP) also develop blood clots. Results may help doctors better assess clot risk in ITP and sort out which antibodies are involved.
Hear when a new Immune Thrombocytopenia (ITP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.